Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US trial for Cook's TAA (thoracic aortic aneurysms) graft

This article was originally published in Clinica

Executive Summary

US researchers are investigating the use of the Cook Group's endovascular medical device for treating thoracic aortic aneurysms (TAA). Based at the Hospital of the University of Pennsylvania (HUP), the STARZ-TX2 trial will enrol 275 patients and include up to 35 institutions in the US and Canada.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts